Gilead Sciences (GILD) EBIT Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
80.35% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
2.93% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
6.88% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-411.15% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
126.32% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
15.60% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-0.98% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-193.55% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
15.60% |
| Dec 31, 2025 |
-19.09% |
| Sep 30, 2025 |
274.66% |
| Jun 30, 2025 |
-6.43% |
| Mar 31, 2025 |
151.76% |
| Dec 31, 2024 |
52.11% |
| Sep 30, 2024 |
-66.15% |
| Jun 30, 2024 |
58.80% |
| Mar 31, 2024 |
-353.49% |
| Dec 31, 2023 |
-28.89% |
| Sep 30, 2023 |
-7.54% |
| Jun 30, 2023 |
-17.94% |
| Mar 31, 2023 |
765.48% |
| Dec 31, 2022 |
141.17% |
| Sep 30, 2022 |
-26.16% |
| Jun 30, 2022 |
-9.66% |
| Mar 31, 2022 |
-93.18% |
| Dec 31, 2021 |
-64.54% |
| Sep 30, 2021 |
92.00% |
| Jun 30, 2021 |
175.29% |
| Mar 31, 2021 |
20.32% |
| Dec 31, 2020 |
142.54% |
| Sep 30, 2020 |
235.85% |
| Jun 30, 2020 |
-222.76% |
| Mar 31, 2020 |
7.38% |
| Dec 31, 2019 |
-4.46% |
| Sep 30, 2019 |
-156.16% |
| Jun 30, 2019 |
6.58% |
| Mar 31, 2019 |
3.90% |
| Dec 31, 2018 |
69.48% |
| Sep 30, 2018 |
-31.19% |
| Jun 30, 2018 |
-46.40% |
| Mar 31, 2018 |
-42.85% |
| Dec 31, 2017 |
-83.31% |
| Sep 30, 2017 |
-13.34% |
| Jun 30, 2017 |
-6.26% |
| Mar 31, 2017 |
-19.01% |
| Dec 31, 2016 |
-28.04% |
| Sep 30, 2016 |
-21.24% |
| Jun 30, 2016 |
-19.20% |
| Mar 31, 2016 |
-13.41% |
| Dec 31, 2015 |
29.82% |
| Sep 30, 2015 |
60.49% |
| Jun 30, 2015 |
27.29% |
| Mar 31, 2015 |
76.50% |
| Dec 31, 2014 |
261.72% |
| Sep 30, 2014 |
203.17% |
| Jun 30, 2014 |
282.38% |
| Mar 31, 2014 |
196.80% |
| Dec 31, 2013 |
8.15% |
| Sep 30, 2013 |
9.96% |
| Jun 30, 2013 |
8.95% |
| Mar 31, 2013 |
28.13% |
| Dec 31, 2012 |
27.59% |
| Sep 30, 2012 |
4.01% |
| Jun 30, 2012 |
4.17% |
| Mar 31, 2012 |
-11.28% |
| Dec 31, 2011 |
4.59% |
| Sep 30, 2011 |
2.51% |
| Jun 30, 2011 |
2.43% |
| Mar 31, 2011 |
-22.32% |
| Dec 31, 2010 |
-22.16% |
| Sep 30, 2010 |
9.47% |
| Jun 30, 2010 |
30.43% |
| Mar 31, 2010 |
43.65% |
